Marley’s One Drop Relaunches in Rexam 12-oz. ‘Sleek’ Can (CSPnet)
Marley’s One Drop coffee beverage recently relaunched in Rexam PLC (LON:REX) 12-ounce “Sleek” cans. Made with premium Jamaican coffee, real cane sugar and all-natural ingredients, Marley’s One Drop is available in coffee, mocha and vanilla light flavors. The company hopes this new package will help it further capitalize on the continued growth in the ready-to-drink (RTD) coffee segment, it said. Originally introduced in 9.5-oz. glass bottles, Marley Beverages chose to move into the Rexam PLC (LON:REX) Sleek can because of its durability, portability and brand differentiation as it helps the beverage stand out on retail shelves. Marley’s also benefits from the fact that aluminum cans are the most sustainable packaging choice in the world, as they are recycled at more than double the rate of any other beverage package.
Marks & Spencer Group Receives Neutral Rating from HSBC (MKS) (DailyPolitical)
Marks and Spencer Group Plc (LON:MKS)‘s stock had its “neutral” rating restated by analysts at HSBC in a research report issued to clients and investors on Wednesday, AnalystRatings.Net reports. They currently have a GBX 490 ($7.53) price target on the stock, up from their previous price target of GBX 390 ($5.99). Several other analysts have also recently commented on the stock. Analysts at Nomura raised their price target on shares of Marks and Spencer Group Plc (LON:MKS) from GBX 500 ($7.69) to GBX 540 ($8.30) in a research note to investors on Wednesday.
M&S chief dismisses talk of being forced out after worst figures in four years (YorkshireEveningPost)
Marks and Spencer Group Plc (LON:MKS)’s chief executive Marc Bolland has dismissed speculation that shareholders could force him out after the group posted its lowest annual profits since 2009. The group warned that growth this year will be held back by investment in online and logistics. Marks and Spencer Group Plc (LON:MKS) will spend £2.4bn over the next three years on store revamps, logistics, IT and systems, as well as investment overseas. It aims to become an international multi-channel retailer, offering customers the chance to shop instore, online, by mobile and on tablets.
AstraZeneca Pharma drops as company skips dividend on poor financials (Business-Standard)
The announcement was made after market hours on Tuesday, 21 May 2013. Meanwhile, the BSE Sensex was up 68.64 points, or 0.34%, to 20,180.25. …AstraZeneca plc (LON:AZN) Pharma India reported net loss of Rs 18.58 crore in Q4 March 2013 as against net loss of Rs 33.01 crore in Q4 March 2012. Net sales rose 3.4% to Rs 94.85 crore in Q4 March 2013 over Q4 March 2012. AstraZeneca plc (LON:AZN) Pharma India is one of the world’s leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare. AstraZeneca plc (LON:AZN) Pharma India is involved in both the manufacturing and marketing of medicines.
AstraZeneca increases production to meet export demand (ManMonthly)
Pharmaceutical company AstraZeneca plc (LON:AZN) Australia is to invest an additional $20.2 million into its Sydney manufacturing operation to boost production of one of its key asthma medications. The move follows growing demand for the medicine from China. Currently medicines earn the Australian economy $3.8 billion in export revenue and the sector employs over 13,000 people. There is potential for those figures to grow significantly in coming years. The extra investment at AstraZeneca plc (LON:AZN) will see capacity for the one asthma medicine alone boosted by an additional 81 per cent from 240 million units currently to 435 million units per year by 2015. The company currently exports $254 million of product, which will rise to $340 million by 2015.
